Amgen Stock Setup On FDA Approval for Multiple Myeloma

Amgen stock looks like a good setup as the Twiggs Money Flow breaks into positive territory.

Summary

  • The FDA has approved Amgen's supplemental Biologics License Application to expand the label of its key drug Xgeva.
  • Amgen stock is in a continuation pattern and the Twiggs Money Flow has just gone positive.
  • Amgen has nearly $39 billion in cash overseas that could be put to use in the United States.
  • TO READ THE FULL STORY SUBSCRIBE OR SIGN IN

    The Computer and Technology portfolio is up more than 440% in the last 6 months! Get these stock picks and more by signing up for the premium service.

    Author: Lance Jepsen

    For ethical purposes, I try not to hold any position in any stock I profile on GuerillaStockTrading.com unless specifically stated in the article. Owner of GuerillaStockTrading.com. Seasoned entrepreneur, investor, and writer. I love God, family, country, stock trading, economics, and helping people learn how to trade.

    Leave a Reply

    Sending